Funding Rounds
AptaTargets

AptaTargets Series A (2017, $2M)

AptaTargets

Therapeutics treatment for strokes and brain injury.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $2.80M